Key statistics
As of last trade Xeris Biopharma Holdings Inc (XERS:NSQ) traded at 6.98, -30.75% below its 52-week high of 10.08, set on Nov 05, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 6.85 |
|---|---|
| High | 7.03 |
| Low | 6.80 |
| Bid | 6.98 |
| Offer | 6.99 |
| Previous close | 6.82 |
| Average volume | 1.14m |
|---|---|
| Shares outstanding | 165.92m |
| Free float | 159.52m |
| P/E (TTM) | -- |
| Market cap | 1.13bn USD |
| EPS (TTM) | -0.1033 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 19:41 GMT.
More ▼
- Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026
- Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue
- Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application
